The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

Blog
Hospitals continue to face challenges with their supply chains and are spending more time than ever trying to manage those supply chains. Hospitals,…
Blog
Effectively managing a hospital’s inventory has always been important. However, it has become even more important over the past several years. Read…
Case Studies
Learn how Rush University Medical Center took an innovative approach to cost reduction and achieved a 21% reduction in the hospital’s shoulder…
This white paper explores the importance of balancing health care supply sourcing through both domestic and international suppliers, the benefits and…
Blog
Read this article and discover three issues hospitals are focusing on to overcome supply chain challenges in 2023.
Webinars
Explore common indirect spend risk considerations and prepare to take steps to introduce resiliency within indirect spend categories.